Tzalir is a global multi-strategy investment and management platform that partners with exceptional asset managers and visionary founders.

Alongside investments in leading established managers, Tzalir provides seed capital to first-time, best-in-class asset managers operating in non-correlated strategies.

Rooted in an investment philosophy that integrates financial excellence with Tikun Olam values, Tzalir is committed to purpose-driven ventures that create meaningful social impact. The firm is also the driving force behind Tzalir Fund —its philanthropic arm—focused on launching and managing large-scale social initiatives that make a real difference in society.

Tzalir is exclusively backed by the single-family office of Meir Jakobsohn, founder and controlling shareholder of Medison.

Meir Jakobsohn is one of the most influential figures in the global healthcare industry and a leading expert in biotech commercialization. Meir’s life mission is carried out by Medison – to ensure that no patient is left behind and has fast access to life changing therapies, regardless of geography.

Meir’s vision has redefined global access to breakthrough therapies and positioned Medison as a category leader and disruptor in the biopharma industry.